Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 7;10(12):2464.
doi: 10.3390/healthcare10122464.

Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine

Giorgio Bogani  1 , Valentina Chiappa  1 , Salvatore Lopez  1 , Christian Salvatore  2 , Matteo Interlenghi  2 , Ottavia D'Oria  3 , Andrea Giannini  3 , Umberto Leone Roberti Maggiore  1 , Giulia Chiarello  1 , Simona Palladino  1 , Ludovica Spano' Bascio  1 , Isabella Castiglioni  4 , Francesco Raspagliesi  1
Affiliations

Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine

Giorgio Bogani et al. Healthcare (Basel). .

Abstract

Molecular/genomic profiling is the most accurate method to assess prognosis of endometrial cancer patients. Radiomic profiling allows for the extraction of mineable high-dimensional data from clinical radiological images, thus providing noteworthy information regarding tumor tissues. Interestingly, the adoption of radiomics shows important results for screening, diagnosis and prognosis, across various radiological systems and oncologic specialties. The central hypothesis of the prospective trial is that combining radiomic features with molecular features might allow for the identification of various classes of risks for endometrial cancer, e.g., predicting unfavorable molecular/genomic profiling. The rationale for the proposed research is that once validated, radiomics applied to ultrasonographic images would be an effective, innovative and inexpensive method for tailoring operative and postoperative treatment modalities in endometrial cancer. Patients with newly diagnosed endometrial cancer will have ultrasonographic evaluation and radiomic analysis of the ultrasonographic images. We will correlate radiomic features with molecular/genomic profiling to classify prognosis.

Keywords: endometrial cancer; genomic; molecular; radiogenomics; radiomics; ultrasound.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 2020;70:7–30. doi: 10.3322/caac.21590. - DOI - PubMed
    1. Bogani G., Tibiletti M.G., Ricci M.T., Carnevali I., Liberale V., Paolini B., Milione M., Vitellaro M., Murgia F., Chiappa V., et al. Lynch syndrome-related non-endometrioid endometrial cancer: Analysis of outcomes. Int. J. Gynecol. Cancer. 2020;30:56–61. doi: 10.1136/ijgc-2019-000824. - DOI - PubMed
    1. Talhouk A., McConechy M.K., Leung S., Yang W., Lum A., Senz J., Boyd N., Pike J., Anglesio M., Kwon J.S., et al. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. Cancer. 2017;123:802–813. doi: 10.1002/cncr.30496. - DOI - PubMed
    1. Murali R., Delair D.F., Bean S.M., Abu-Rustum N.R., Soslow R.A. Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer. J. Natl. Compr. Cancer Netw. 2018;16:201–209. doi: 10.6004/jnccn.2017.7066. - DOI - PMC - PubMed
    1. Bosse T., Nout R.A., McAlpine J.N., McConechy M.K., Britton H., Hussein Y.R., Gonzalez C., Ganesan R., Steele J.C., Harrison B.T., et al. Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups. Am. J. Surg. Pathol. 2018;42:561–568. doi: 10.1097/PAS.0000000000001020. - DOI - PMC - PubMed

LinkOut - more resources